Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-061720
Filing Date
2013-11-14
Accepted
2013-11-14 14:58:39
Documents
9
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v357616_10q.htm 10-Q 691736
2 EXHIBIT 31.1 v357616_ex31-1.htm EX-31.1 11727
3 EXHIBIT 32.1 v357616_ex32-1.htm EX-32.1 7079
  Complete submission text file 0001144204-13-061720.txt   4200765

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ttnp-20130930.xml EX-101.INS 601576
5 XBRL TAXONOMY EXTENSION SCHEMA ttnp-20130930.xsd EX-101.SCH 32497
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttnp-20130930_cal.xml EX-101.CAL 28555
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttnp-20130930_def.xml EX-101.DEF 147008
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttnp-20130930_lab.xml EX-101.LAB 217363
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttnp-20130930_pre.xml EX-101.PRE 202553
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27436 | Film No.: 131219265
SIC: 2836 Biological Products, (No Diagnostic Substances)